| CAS NO: | 138660-96-5 |
| 包装 | 价格(元) |
| 100mg | 电议 |
| 250mg | 电议 |
| 500mg | 电议 |
| 生物活性 | Sevirumab (MSL-109) is a humanIgG1neutralizing monoclonal antibody against cytomegalovirus (CMV). Sevirumab recognizesCMVgH complexes and inhibitsCMVreplication with anEC50of 0.3 μg/mL[1][2]. |
| IC50& Target | EC50: 0.3 μg/mL (CMV)[1] |
| 体外研究 (In Vitro) | Sevirumab (MSL-109) 扰乱 gH/gL 同型二聚体，而不是取消二聚。Sevirumab 可以将二聚体在足够的距离上分开，以减少荧光共振能量转移 (FRET)，并最终阻止正常的 gH/gL 功能[2]。 |
| CAS 号 | 138660-96-5 |
| 中文名称 | 司韦单抗 |
| 储存方式 | Please store the product under the recommended conditions in the Certificate of Analysis. |
m.cnreagent.com